10/13/2026
Exciting progress in congenital heart care. ❤️
The FDA has approved the first heart valve designed to grow with children, potentially reducing the need for repeat surgeries as children grow.
Innovations like this reinforce something we believe deeply at Sisters by Heart: the experiences of patients and families matter as new devices, therapies and clinical trials are developed.
The future of congenital heart care is strongest when researchers, clinicians, regulators, industry, patients and families all have a seat at the table.
Today, we approved the first heart valve device designed to grow with children. The Autus Size-Adjustable Valve, a surgically implanted pulmonary heart valve for pediatric patients with congenital pulmonary valve disease can be expanded after surgery to keep pace with growth. The adjustable valve may mean fewer repeat surgeries for children as they get older.
https://www.fda.gov/news-events/press-announcements/fda-approves-first-heart-valve-designed-grow-children
Congenital heart defects are among the most common types of birth defects in the United States, affecting about 1 in every 100 births. The valve was approved through the premarket approval pathway, the FDA's most rigorous review process for medical devices.